Then (1960), Moksha: Letters of Huxley & Osmond
The Integration Problem: What Huxley Got Right That the Clinic Is Still Solving
Huxley was explicit in the Moksha letters that the psychedelic experience requires integration, that what you experience in the session must be worked with afterward to become part of how you live. He distinguished the experience (accessible through the drug) from the transformation (requiring work the drug cannot do). This distinction was less emphasized in the clinical literature of the 1960s, which focused on the session itself.
contested
Integration, what happens after the psychedelic session to consolidate its insights, is now recognized as potentially the most important variable in determining long-term outcomes. The FDA's concerns about the MDMA-assisted therapy program (August 2024) explicitly cited inadequate integration support. The synthetic psilocybin protocol includes multiple integration sessions. MAPS's MDMA-AT protocol specifies three 90-minute preparation sessions and three integration sessions for every drug session. A 2023 Frontiers in Psychiatry review (Horton et al.) found integration quality was the strongest predictor of 12-month outcomes across multiple indications. Huxley's distinction between the experience and the transformation it enables is now the primary clinical design variable in psychedelic-assisted therapy.
Sources
- FDA complete response letter on the MDMA-assisted therapy application (August 2024)
- Horton et al., Frontiers in Psychiatry (2023) [Source not found; under review]
- MAPS MDMA-AT Treatment Manual (2023)